Signature Wealth Management Partners’s iShares Biotechnology ETF IBB Stock Holding History

Signature Wealth Management Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45M	Sell	7,606 -49	-0.6%	-$8.42K	0.67%	31
2026 Q1	$1.29M	Buy	7,655 +135	+2%	+$23.1K	0.65%	34
2025 Q4	$1.27M	Hold	7,520	–	–	0.63%	34
2025 Q3	$1.09M	Sell	7,520 -150	-2%	-$20.5K	0.57%	35
2025 Q2	$970K	Sell	7,670 -277	-3%	-$34K	0.55%	36
2025 Q1	$1.02M	Hold	7,947	–	–	0.67%	29
2024 Q4	$1.05M	Sell	7,947 -75	-0.9%	-$10.5K	0.72%	26
2024 Q3	$1.17M	Sell	8,022 -3,024	-27%	-$438K	0.85%	24
2024 Q2	$1.52M	Sell	11,046 -732	-6%	-$97.7K	1.15%	17
2024 Q1	$1.62M	Sell	11,778 -213	-2%	-$29.1K	1.32%	16
2023 Q4	$1.63M	Sell	11,991 -101	-0.8%	-$12.3K	1.43%	13
2023 Q3	$1.48M	Sell	12,092 -95	-0.8%	-$12.1K	1.45%	13
2023 Q2	$1.55M	Sell	12,187 -186	-2%	-$24.2K	1.43%	13
2023 Q1	$1.6M	Buy	12,373 +78	+0.6%	+$10.2K	1.48%	15
2022 Q4	$1.61M	Sell	12,295 -289	-2%	-$37.3K	1.59%	14
2022 Q3	$1.47M	Hold	12,584	–	–	1.62%	13
2022 Q2	$1.48M	Hold	12,584	–	–	1.52%	15
2022 Q1	$1.64M	Sell	12,584 -199	-2%	-$25.9K	1.4%	17
2021 Q4	$1.95M	Hold	12,783	–	–	1.65%	13
2021 Q3	$2.07M	Sell	12,783 -305	-2%	-$51.3K	1.87%	13
2021 Q2	$2.14M	Sell	13,088 -1,461	-10%	-$225K	1.94%	13
2021 Q1	$2.19M	Buy	14,549 +214	+1%	+$34K	2.1%	12
2020 Q4	$2.17M	Buy	+14,335	New	+$2.05M	2.17%	12

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Signature Wealth Management Partners's IBB Position: Q2 2026 in Review

Signature Wealth Management Partners reduced its iShares Biotechnology ETF (IBB) stake by 0.64% in Q2 2026, selling an estimated $8.42K and leaving 7,606 shares worth $1.45M. The position accounts for 0.67% of the portfolio, ranked #31.

Signature Wealth Management Partners first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.19M in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Signature Wealth Management Partners held 7,606 shares of iShares Biotechnology ETF worth $1.45M as of Q2 2026.
Signature Wealth Management Partners sold 49 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.42K.
iShares Biotechnology ETF made up 0.67% of Signature Wealth Management Partners's portfolio in Q2 2026, its #31 holding.
Signature Wealth Management Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
Signature Wealth Management Partners's iShares Biotechnology ETF position peaked at $2.19M in Q1 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Signature Wealth Management Partners's 13F filing for Q2 2026, filed 29 Jul 2026.